Recent research into cannabidiol (CBD), a non-psychoactive cannabinoid, shows promising signs for the treatment of several psychiatric conditions, according to a critical review of existing studies. The review focused on clinical studies published before July 27, 2023, scrutinizing the effects of CBD on conditions such as schizophrenia, substance use disorders (SUDs), anxiety, post-traumatic stress disorder … Read more
As interest in medical uses of cannabis constituents grows, researchers are closely examining how cannabidiol (CBD), a naturally occurring compound in plants, impacts health, especially regarding cancer and inflammatory diseases. CBD is recognized for its antidepressant, anxiolytic, and antiepileptic properties, and now, scientists are exploring its ability to regulate essential cellular functions like autophagy and … Read more
In a promising development for lung cancer treatment, a recent study has unveiled that combining low doses of the chemotherapy drug dasatinib with cannabidiol (CBD), a compound derived from cannabis, significantly enhances the efficacy of cancer therapy while reducing its side effects. This groundbreaking research could pave the way for new treatment protocols that are … Read more
In a pivotal study, researchers have identified a promising new treatment approach for glioblastoma (GBM), an aggressive brain cancer with limited effective treatments and a typically poor prognosis. The research focuses on the potential therapeutic effects of inhalant cannabidiol (CBD), a non-psychoactive compound derived from cannabis. Glioblastoma is notoriously challenging due to its fast growth … Read more
A pivotal review has brought cannabidiol (CBD) into the spotlight, reaffirming its potential as a game-changer in the treatment of epilepsy, especially in its drug-resistant forms. Centered on Epidiolex, a refined pharmaceutical version of CBD and the first cannabis-derived medication approved by regulators, the study provides profound insights into CBD’s therapeutic benefits. The research delves … Read more
In recent research that could redefine treatment approaches for schizophrenia, cannabidiol (CBD), a non-psychoactive component of cannabis, is being highlighted for its potential to manage symptoms associated with the mental health disorder. Schizophrenia, which affects 1% of adults globally, has one of the highest mortality rates among psychiatric conditions, underscoring the urgency for more effective … Read more
In a groundbreaking study, researchers have revealed that CBD may offer new hope in the fight against liver fibrosis. This condition, which can progress to severe liver diseases such as cirrhosis and hepatocellular carcinoma, poses a significant public health challenge. The study utilized a mouse model with liver fibrosis induced by carbon tetrachloride (CCl4), a … Read more
A recent Forbes Health survey conducted by OnePoll has highlighted a significant trend among Gen Z users of cannabidiol (CBD), with 22% reporting they use CBD to alleviate menstrual cramps. This finding is part of a broader examination into the expanding use of CBD products across various age groups in the United States, reflecting the … Read more
In a groundbreaking study, researchers have unearthed nuanced findings about the effects of cannabidiol (CBD) on brain cells, revealing that while low doses of the compound can protect against certain types of cell damage, higher doses may actually be harmful. This new research highlights the complex nature of CBD’s interaction with the brain’s neuronal cells … Read more
Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, continues to capture the interest of the medical community due to its wide-ranging potential therapeutic benefits. Notably, recent research has shown its efficacy in managing certain types of drug-resistant epilepsies and has hinted at potential benefits for anxiety, chronic pain, and inflammatory disorders based on animal studies. … Read more